ANVESHAN
Theme
Create account
ICICI Prudential · Other ETFs

ICICI Prudential Nifty Healthcare ETF

Other Scheme - Other ETFs Regular plan riskometer: Very high benchmark: Nifty Healthcare TRI launched 6 May 2021 open-ended

At a glance

the fund as it stands today, from public disclosures

NAV, 21 Sep 2026
₹172.44
+1.10% since 18 Sep 2026, the previous NAV
1 year
14.5%
return
3 years
21.0%
a year
5 years
14.0%
a year
Since launch
14.5%
a year, over 5.3 years
Assets (AUM)
₹233 Cr
Aug 2026 factsheet
Expense ratio, Direct / Regular
0.00% / 0.13%
a year, as of Aug 2026
Holdings
22
top ten are 77% of the fund · Aug 2026
Disclosed history
5.3 yrs
May 2021 – Aug 2026 · 5 of 11 checks could run
Fund managers
Nishit Patel · since May 2021Ashwini Bharucha · since Nov 2024Venus Ahuja · since Oct 2025

As the Aug 2026 factsheet printed it: standard deviation 16.4% · portfolio turnover 0.35×. Exit load and minimum investment are not yet extracted from the scheme documents.

What only Anveshan can tell you

measured from the disclosures, not quoted from a brochure — each links to how it was done

P5Cost, measured

Cannot be measured: needs both a Direct and a Regular growth class.

The Regular and Direct plans hold the same portfolio; the Regular one pays a distributor out of your money every day. The gap between the two NAVs is that cost, measured from the NAVs rather than quoted from a document.

See how it is measured →
P7Whose record

Run by Nishit Patel for 5.3 yrs

with Ashwini Bharucha, Venus Ahuja. A return earned before they arrived is the house's record, not theirs — the tenure table shows the fund against its category over exactly their months.

Nishit Patel's other funds →
NAVTracking gap

Not replicated: the portfolio cannot be priced line by line in this build.

Each day, the NAV the fund published against the NAV its last disclosed portfolio would have produced at that day's prices. A gap that opens and stays is a change the fund has made and not disclosed yet.

See the daily gap →
P4Consistency

Beat its category in 90% of three-year stretches, and averaged +6.2 points a year across all of them

29 rolling windows since 2021 · ahead by 7.3 points a year when it won, behind by 3.5 when it lost. A single five-year figure depends on the day you look; the share of stretches won does not — and the average margin says whether winning often was worth anything.

See every window →

headline and record disagree 2 checks found the headline number and the underlying record pointing different ways — marked on the cards below.

NAV and drawdown

Regular plan class · as of 21 Sep 2026

Month-end NAV, indexed to 100 at May 2021

100150200May 2021Sep 2022Feb 2024Jun 2025Sep 2026May 2021: NAV ₹84.00Jun 2021: NAV ₹87.76Jul 2021: NAV ₹89.18Aug 2021: NAV ₹91.73Sep 2021: NAV ₹89.86Oct 2021: NAV ₹86.19Nov 2021: NAV ₹88.01Dec 2021: NAV ₹89.77Jan 2022: NAV ₹82.41Feb 2022: NAV ₹81.29Mar 2022: NAV ₹84.98Apr 2022: NAV ₹84.37May 2022: NAV ₹78.31Jun 2022: NAV ₹75.38Jul 2022: NAV ₹80.55Aug 2022: NAV ₹80.76Sep 2022: NAV ₹82.76Oct 2022: NAV ₹84.66Nov 2022: NAV ₹84.44Dec 2022: NAV ₹80.62Jan 2023: NAV ₹79.01Feb 2023: NAV ₹75.76Mar 2023: NAV ₹76.98Apr 2023: NAV ₹80.93May 2023: NAV ₹82.92Jun 2023: NAV ₹90.25Jul 2023: NAV ₹96.87Aug 2023: NAV ₹96.10Sep 2023: NAV ₹98.54Oct 2023: NAV ₹93.83Nov 2023: NAV ₹104.32Dec 2023: NAV ₹107.84Jan 2024: NAV ₹115.77Feb 2024: NAV ₹121.36Mar 2024: NAV ₹122.44Apr 2024: NAV ₹121.57May 2024: NAV ₹119.74Jun 2024: NAV ₹127.67Jul 2024: NAV ₹139.83Aug 2024: NAV ₹147.73Sep 2024: NAV ₹150.21Oct 2024: NAV ₹146.89Nov 2024: NAV ₹143.82Dec 2024: NAV ₹152.20Jan 2025: NAV ₹140.37Feb 2025: NAV ₹129.36Mar 2025: NAV ₹139.46Apr 2025: NAV ₹143.25May 2025: NAV ₹141.58Jun 2025: NAV ₹147.55Jul 2025: NAV ₹152.16Aug 2025: NAV ₹146.78Sep 2025: NAV ₹144.65Oct 2025: NAV ₹150.31Nov 2025: NAV ₹153.75Dec 2025: NAV ₹149.73Jan 2026: NAV ₹142.08Feb 2026: NAV ₹152.34Mar 2026: NAV ₹145.46Apr 2026: NAV ₹152.79May 2026: NAV ₹157.67Jun 2026: NAV ₹165.41Jul 2026: NAV ₹172.01Aug 2026: NAV ₹173.94Sep 2026: NAV ₹172.44
100150200May 2021Sep 2022Feb 2024Jun 2025Sep 2026May 2021: NAV ₹84.00Jun 2021: NAV ₹87.76Jul 2021: NAV ₹89.18Aug 2021: NAV ₹91.73Sep 2021: NAV ₹89.86Oct 2021: NAV ₹86.19Nov 2021: NAV ₹88.01Dec 2021: NAV ₹89.77Jan 2022: NAV ₹82.41Feb 2022: NAV ₹81.29Mar 2022: NAV ₹84.98Apr 2022: NAV ₹84.37May 2022: NAV ₹78.31Jun 2022: NAV ₹75.38Jul 2022: NAV ₹80.55Aug 2022: NAV ₹80.76Sep 2022: NAV ₹82.76Oct 2022: NAV ₹84.66Nov 2022: NAV ₹84.44Dec 2022: NAV ₹80.62Jan 2023: NAV ₹79.01Feb 2023: NAV ₹75.76Mar 2023: NAV ₹76.98Apr 2023: NAV ₹80.93May 2023: NAV ₹82.92Jun 2023: NAV ₹90.25Jul 2023: NAV ₹96.87Aug 2023: NAV ₹96.10Sep 2023: NAV ₹98.54Oct 2023: NAV ₹93.83Nov 2023: NAV ₹104.32Dec 2023: NAV ₹107.84Jan 2024: NAV ₹115.77Feb 2024: NAV ₹121.36Mar 2024: NAV ₹122.44Apr 2024: NAV ₹121.57May 2024: NAV ₹119.74Jun 2024: NAV ₹127.67Jul 2024: NAV ₹139.83Aug 2024: NAV ₹147.73Sep 2024: NAV ₹150.21Oct 2024: NAV ₹146.89Nov 2024: NAV ₹143.82Dec 2024: NAV ₹152.20Jan 2025: NAV ₹140.37Feb 2025: NAV ₹129.36Mar 2025: NAV ₹139.46Apr 2025: NAV ₹143.25May 2025: NAV ₹141.58Jun 2025: NAV ₹147.55Jul 2025: NAV ₹152.16Aug 2025: NAV ₹146.78Sep 2025: NAV ₹144.65Oct 2025: NAV ₹150.31Nov 2025: NAV ₹153.75Dec 2025: NAV ₹149.73Jan 2026: NAV ₹142.08Feb 2026: NAV ₹152.34Mar 2026: NAV ₹145.46Apr 2026: NAV ₹152.79May 2026: NAV ₹157.67Jun 2026: NAV ₹165.41Jul 2026: NAV ₹172.01Aug 2026: NAV ₹173.94Sep 2026: NAV ₹172.44
100150200May 2021Sep 2022Feb 2024Jun 2025Sep 2026May 2021: NAV ₹84.00Jun 2021: NAV ₹87.76Jul 2021: NAV ₹89.18Aug 2021: NAV ₹91.73Sep 2021: NAV ₹89.86Oct 2021: NAV ₹86.19Nov 2021: NAV ₹88.01Dec 2021: NAV ₹89.77Jan 2022: NAV ₹82.41Feb 2022: NAV ₹81.29Mar 2022: NAV ₹84.98Apr 2022: NAV ₹84.37May 2022: NAV ₹78.31Jun 2022: NAV ₹75.38Jul 2022: NAV ₹80.55Aug 2022: NAV ₹80.76Sep 2022: NAV ₹82.76Oct 2022: NAV ₹84.66Nov 2022: NAV ₹84.44Dec 2022: NAV ₹80.62Jan 2023: NAV ₹79.01Feb 2023: NAV ₹75.76Mar 2023: NAV ₹76.98Apr 2023: NAV ₹80.93May 2023: NAV ₹82.92Jun 2023: NAV ₹90.25Jul 2023: NAV ₹96.87Aug 2023: NAV ₹96.10Sep 2023: NAV ₹98.54Oct 2023: NAV ₹93.83Nov 2023: NAV ₹104.32Dec 2023: NAV ₹107.84Jan 2024: NAV ₹115.77Feb 2024: NAV ₹121.36Mar 2024: NAV ₹122.44Apr 2024: NAV ₹121.57May 2024: NAV ₹119.74Jun 2024: NAV ₹127.67Jul 2024: NAV ₹139.83Aug 2024: NAV ₹147.73Sep 2024: NAV ₹150.21Oct 2024: NAV ₹146.89Nov 2024: NAV ₹143.82Dec 2024: NAV ₹152.20Jan 2025: NAV ₹140.37Feb 2025: NAV ₹129.36Mar 2025: NAV ₹139.46Apr 2025: NAV ₹143.25May 2025: NAV ₹141.58Jun 2025: NAV ₹147.55Jul 2025: NAV ₹152.16Aug 2025: NAV ₹146.78Sep 2025: NAV ₹144.65Oct 2025: NAV ₹150.31Nov 2025: NAV ₹153.75Dec 2025: NAV ₹149.73Jan 2026: NAV ₹142.08Feb 2026: NAV ₹152.34Mar 2026: NAV ₹145.46Apr 2026: NAV ₹152.79May 2026: NAV ₹157.67Jun 2026: NAV ₹165.41Jul 2026: NAV ₹172.01Aug 2026: NAV ₹173.94Sep 2026: NAV ₹172.44

65 month-ends · ₹84.00 → ₹172.44, 2.1× since May 2021

Deepest fall (max drawdown)
−15.7%
2 Jan 2025 → 28 Feb 2025
Worst month
−7.8%
Feb 2025
Days to recover
151
from the deepest trough back to the old high

Drawdown is measured on the last year of daily NAV; trailing returns are CAGR of the regular growth class. A single end date decides them — the consistency card (P4) below is the record that does not, and it reports both how often the fund beat its category and by how much, because the first without the second can point the wrong way.

Holdings

Aug 2026 disclosure · 22 lines · when each was first held and the change over the last three disclosures

#HoldingSectorWeightFirst heldHeld for3-mo change
1 Sun Pharmaceutical Industries Ltd.
equity
Pharmaceuticals & Biotechnology 18.08% May 2021 5.3 yrs -0.29%
2 Divi's Laboratories Ltd.
equity
Pharmaceuticals & Biotechnology 10.35% May 2021 5.3 yrs +2.18%
3 Apollo Hospitals Enterprise Ltd.
equity
Healthcare Services 7.88% May 2021 5.3 yrs -0.23%
4 Cipla Ltd.
equity
Pharmaceuticals & Biotechnology 6.82% May 2021 5.3 yrs -0.78%
5 MAX Healthcare Institute Ltd
equity
Healthcare Services 6.67% Mar 2023 3.5 yrs -0.25%
6 Laurus Labs Ltd.
equity
Pharmaceuticals & Biotechnology 6.41% May 2021 5.3 yrs +1.30%
7 Torrent Pharmaceuticals Ltd.
equity
Pharmaceuticals & Biotechnology 6.39% May 2021 5.3 yrs +1.94%
8 Dr. Reddy's Laboratories Ltd.
equity
Pharmaceuticals & Biotechnology 6.05% Oct 2024 1.9 yrs -1.61%
9 Lupin Ltd.
equity
Pharmaceuticals & Biotechnology 4.57% May 2021 5.3 yrs -0.73%
10 Aurobindo Pharma Ltd.
equity
Pharmaceuticals & Biotechnology 4.09% May 2021 5.3 yrs +0.24%
Showing 1–10 of 22 · page 1 of 3 rows per page102550all

Largest sectors, Aug 2026 · grey: a year ago

Pharmaceuticals & Biotechnology80.7% · 76.8%
Healthcare Services19.3% · 23.2%
share of the book05%10%15%20%25%30%35%40%45%50%55%60%65%70%75%80%85%

By market cap, Aug 2026

Large cap55.6%
Mid cap36.9%
Small / micro cap7.6%
share of the book025%50%75%100%

Composition by market cap, month by month — what the fund actually held against what its label says

Large cap: 45% → 56%Mid cap: 27% → 37%Small / micro: 11% → 8%Cash & other: 0% → 0%25%50%75%May 2021Jan 2024Aug 2026
Large cap: 45% → 56%Mid cap: 27% → 37%Small / micro: 11% → 8%Cash & other: 0% → 0%25%50%75%Large cap 56%Mid cap 37%Small / micro 8%May 2021Jan 2024Aug 2026
Large cap: 45% → 56%Mid cap: 27% → 37%Small / micro: 11% → 8%Cash & other: 0% → 0%25%50%75%Large cap 56%Mid cap 37%Small / micro 8%May 2021Jan 2024Aug 2026
  • Large cap 56%
  • Mid cap 37%
  • Small / micro 8%
  • Cash & other 0%

The seven checks, in full

each: the plain claim, where it sits in the category, and — folded — how it is measured and the case against. A flag fires only where headline and record disagree.

P4 Consistency, not a single end date headline and record disagree

Beat its category in 90% of three-year stretches, and averaged +6.2 points a year across all of them

29 rolling windows since 2021 · ahead by 7.3 points a year when it won, behind by 3.5 when it lost

What this means. Take every three-year stretch since the fund had a NAV, one starting each month, and ask two things of each: did it beat the typical fund in its category, and by how much. Counting the wins tells you the record does not depend on when you happen to look; averaging the margin tells you whether winning often was worth anything, because four small wins do not pay for one large loss.

How often, and by how much. The count and the average agree. Ahead by 7.3 points a year in the 26 windows it won and behind by 3.5 in the 3 it lost, so the average across all 29 is +6.2 points. The worst window ended Jun 2024, 4.4 points behind.

windows measured29windows won26average across every window+6.19 pts a year · median +6.07when ahead, by how much+7.32 pts a year over 26 windowswhen behind, by how much−3.55 pts a year over 3 windowsworst window−4.44 pts a year, ended Jun 2024best window+12.53 pts a year, ended Mar 2026non-overlapping windows in that span1 — the rolling count overlaps, this does not
Thin record. Only 29 rolling windows — under six years of NAV. The share is shown because it was measured; it is a start, not a record, and does not qualify for the home shelf until 36 windows exist.

Fund minus category, each rolling three-year window

-12.5 pp0.0 pp+12.5 ppMay 2024: fund 12.5% vs category 15.7% (3-year CAGR)Jun 2024: fund 13.3% vs category 17.8% (3-year CAGR)Jul 2024: fund 16.2% vs category 19.2% (3-year CAGR)Aug 2024: fund 17.2% vs category 17.1% (3-year CAGR)Sep 2024: fund 18.7% vs category 17.0% (3-year CAGR)Oct 2024: fund 19.4% vs category 14.6% (3-year CAGR)Nov 2024: fund 17.8% vs category 15.3% (3-year CAGR)Dec 2024: fund 19.2% vs category 13.7% (3-year CAGR)Jan 2025: fund 19.4% vs category 13.4% (3-year CAGR)Feb 2025: fund 16.8% vs category 11.8% (3-year CAGR)Mar 2025: fund 17.9% vs category 12.7% (3-year CAGR)Apr 2025: fund 19.3% vs category 14.3% (3-year CAGR)May 2025: fund 21.8% vs category 16.1% (3-year CAGR)Jun 2025: fund 25.1% vs category 19.4% (3-year CAGR)Jul 2025: fund 23.6% vs category 14.9% (3-year CAGR)Aug 2025: fund 22.0% vs category 13.1% (3-year CAGR)Sep 2025: fund 20.5% vs category 14.7% (3-year CAGR)Oct 2025: fund 21.1% vs category 14.6% (3-year CAGR)Nov 2025: fund 22.1% vs category 13.8% (3-year CAGR)Dec 2025: fund 22.9% vs category 15.1% (3-year CAGR)Jan 2026: fund 21.6% vs category 15.1% (3-year CAGR)Feb 2026: fund 26.2% vs category 15.8% (3-year CAGR)Mar 2026: fund 23.6% vs category 11.1% (3-year CAGR)Apr 2026: fund 23.6% vs category 12.8% (3-year CAGR)May 2026: fund 23.9% vs category 11.7% (3-year CAGR)Jun 2026: fund 22.4% vs category 10.9% (3-year CAGR)Jul 2026: fund 21.1% vs category 10.4% (3-year CAGR)Aug 2026: fund 21.9% vs category 10.8% (3-year CAGR)Sep 2026: fund 20.5% vs category 9.2% (3-year CAGR)May 2024Aug 2025Sep 2026
-12.5 pp0.0 pp+12.5 ppMay 2024: fund 12.5% vs category 15.7% (3-year CAGR)Jun 2024: fund 13.3% vs category 17.8% (3-year CAGR)Jul 2024: fund 16.2% vs category 19.2% (3-year CAGR)Aug 2024: fund 17.2% vs category 17.1% (3-year CAGR)Sep 2024: fund 18.7% vs category 17.0% (3-year CAGR)Oct 2024: fund 19.4% vs category 14.6% (3-year CAGR)Nov 2024: fund 17.8% vs category 15.3% (3-year CAGR)Dec 2024: fund 19.2% vs category 13.7% (3-year CAGR)Jan 2025: fund 19.4% vs category 13.4% (3-year CAGR)Feb 2025: fund 16.8% vs category 11.8% (3-year CAGR)Mar 2025: fund 17.9% vs category 12.7% (3-year CAGR)Apr 2025: fund 19.3% vs category 14.3% (3-year CAGR)May 2025: fund 21.8% vs category 16.1% (3-year CAGR)Jun 2025: fund 25.1% vs category 19.4% (3-year CAGR)Jul 2025: fund 23.6% vs category 14.9% (3-year CAGR)Aug 2025: fund 22.0% vs category 13.1% (3-year CAGR)Sep 2025: fund 20.5% vs category 14.7% (3-year CAGR)Oct 2025: fund 21.1% vs category 14.6% (3-year CAGR)Nov 2025: fund 22.1% vs category 13.8% (3-year CAGR)Dec 2025: fund 22.9% vs category 15.1% (3-year CAGR)Jan 2026: fund 21.6% vs category 15.1% (3-year CAGR)Feb 2026: fund 26.2% vs category 15.8% (3-year CAGR)Mar 2026: fund 23.6% vs category 11.1% (3-year CAGR)Apr 2026: fund 23.6% vs category 12.8% (3-year CAGR)May 2026: fund 23.9% vs category 11.7% (3-year CAGR)Jun 2026: fund 22.4% vs category 10.9% (3-year CAGR)Jul 2026: fund 21.1% vs category 10.4% (3-year CAGR)Aug 2026: fund 21.9% vs category 10.8% (3-year CAGR)Sep 2026: fund 20.5% vs category 9.2% (3-year CAGR)May 2024Aug 2025Sep 2026
-12.5 pp0.0 pp+12.5 ppMay 2024: fund 12.5% vs category 15.7% (3-year CAGR)Jun 2024: fund 13.3% vs category 17.8% (3-year CAGR)Jul 2024: fund 16.2% vs category 19.2% (3-year CAGR)Aug 2024: fund 17.2% vs category 17.1% (3-year CAGR)Sep 2024: fund 18.7% vs category 17.0% (3-year CAGR)Oct 2024: fund 19.4% vs category 14.6% (3-year CAGR)Nov 2024: fund 17.8% vs category 15.3% (3-year CAGR)Dec 2024: fund 19.2% vs category 13.7% (3-year CAGR)Jan 2025: fund 19.4% vs category 13.4% (3-year CAGR)Feb 2025: fund 16.8% vs category 11.8% (3-year CAGR)Mar 2025: fund 17.9% vs category 12.7% (3-year CAGR)Apr 2025: fund 19.3% vs category 14.3% (3-year CAGR)May 2025: fund 21.8% vs category 16.1% (3-year CAGR)Jun 2025: fund 25.1% vs category 19.4% (3-year CAGR)Jul 2025: fund 23.6% vs category 14.9% (3-year CAGR)Aug 2025: fund 22.0% vs category 13.1% (3-year CAGR)Sep 2025: fund 20.5% vs category 14.7% (3-year CAGR)Oct 2025: fund 21.1% vs category 14.6% (3-year CAGR)Nov 2025: fund 22.1% vs category 13.8% (3-year CAGR)Dec 2025: fund 22.9% vs category 15.1% (3-year CAGR)Jan 2026: fund 21.6% vs category 15.1% (3-year CAGR)Feb 2026: fund 26.2% vs category 15.8% (3-year CAGR)Mar 2026: fund 23.6% vs category 11.1% (3-year CAGR)Apr 2026: fund 23.6% vs category 12.8% (3-year CAGR)May 2026: fund 23.9% vs category 11.7% (3-year CAGR)Jun 2026: fund 22.4% vs category 10.9% (3-year CAGR)Jul 2026: fund 21.1% vs category 10.4% (3-year CAGR)Aug 2026: fund 21.9% vs category 10.8% (3-year CAGR)Sep 2026: fund 20.5% vs category 9.2% (3-year CAGR)May 2024Aug 2025Sep 2026
ahead of categorybehind

Each bar is one window's margin in percentage points a year. The height of the bars, not the count of green ones, is what the average across every window measures.

A modest five-year number over a record that beat its category 90% of the time. Rolling every three-year window forward month by month gives hundreds of overlapping observations instead of one. This fund was ahead of its category median in 90% of them, which points the opposite way to the headline figure. A single end date decided that headline.
How it is measured, and the case against

A fund that beats its category in most rolling three-year windows has a record; one that beats it in a few has an end date. How often it won and by how much are different questions, and this card answers both, because a fund can win four windows in five and still be behind across all five.

How often has it beaten its category, across every window?

Why this might matterRolling every three-year window forward month by month gives hundreds of overlapping observations instead of one. A single end date decides a headline five-year figure; the share of windows won cannot be flattered by when you happen to look. The average margin across every window is that share and the payoff multiplied together — win share x average beat plus loss share x average shortfall is exactly the average — so a high share bought with a few ruinous windows cannot hide behind the count.
Why it might notRolling windows overlap heavily, so they are not independent observations and the true sample is far smaller than the count suggests.
P5 Cost, measured
Not measurable yet. Needs a Direct and a Regular growth class with overlapping NAV history.

What this means. The Regular and Direct plans hold the same portfolio; the Regular one pays a distributor out of your money every day. The gap between the two NAVs is that cost, measured from the NAVs rather than quoted from a document.

How it is measured, and the case against

The Direct plan is the same portfolio, priced differently; the divergence of the two NAVs is the cost, measured rather than quoted.

What does the Regular plan actually cost against its Direct twin?

Why this might matterSame manager, same holdings, same day. The gap between the two NAV series is the one number on this page that is knowable today rather than hoped for, and it compounds for as long as the units are held.
Why it might notA Regular plan buys advice. If that advice stops someone selling in a drawdown it can be worth more than the fee — the cost is visible and the behavioural saving is not, which makes this comparison unfair in exactly one direction.
P1 Churn, and what it bought

Turns over 28% of the portfolio a year

+0.48 pts of excess return per unit of turnover

What this means. How much of the portfolio was bought and sold in a year, computed from what the fund disclosed each month. Trading costs something certain; the extra return it is meant to buy is not.

excess return per unit of turnover+0.48 pts
How it is measured, and the case against

Turnover measured from consecutive disclosures — Σ|Δweight|/2 — costs something certain; the excess return it is meant to buy is not.

Is the trading paying for itself?

Why this might matterAMCs define their own turnover figure inconsistently. This one is computed from what the fund disclosed month to month, so two funds are comparable on it. Read it beside the excess return per unit of turnover.
Why it might notTurnover computed from month-end snapshots misses everything bought and sold inside a month, and a fund forced to sell by redemptions is charged for churn it did not choose.
P2 Conviction or inertia

Typical top-10 holding kept 64 months

What this means. How long a typical top-10 position has been in the top ten. Long-held positions are a decision; a top ten that changes every quarter is a reaction.

active sharenot yet computable — needs index constituent files
How it is measured, and the case against

The median months a top-10 position has been held separates a portfolio somebody chose from one that drifted.

How long does a top-10 position stay a top-10 position?

Why this might matterConcentration is how a manager expresses conviction, and persistence is how long they keep it. Long-held positions with a rising weight are a decision; a top ten that turns over every quarter is a reaction.
Why it might notPersistence without active share is inertia: a portfolio of 166 names that tracks its category closely has diversified away the reason to pay for it. Active share needs index constituent files, which are not loaded yet.
P3 Hit rate of the top ten

6 of 10 top picks beat their peers over the next 6 months, and averaged 3.6 points ahead of them

580 positions judged, one disclosure at a time · ahead by 13.8 points when it won, behind by 11.4 when it lost

What this means. Take each month's ten largest holdings and check whether each one beat the typical stock its category holds over the next six months, and by how much. A blended return can hide two wins and eight losses; a count of wins can hide one position that lost half its value.

How often, and by how much. The count and the average agree. Ahead by 13.8 points in the 343 positions it won and behind by 11.4 in the 237 it lost, so the average across all 580 is +3.6 points. The worst position was INE406A01037 at the May 2021 disclosure, 42.7 points behind.

positions judged580beat the median stock343average across every position+3.59 pts · median +2.66when ahead, by how much+13.85 pts over 343 positionswhen behind, by how much−11.37 pts over 237 positionsworst position−42.70 pts, INE406A01037 at the May 2021 disclosurebest position+82.87 pts, INE947Q01028 at the Jan 2026 disclosure
How it is measured, and the case against

A manager's largest bets, judged one by one over the following six months, say more than the fund's blended return — and how far each one beat or missed the median stock says more than counting how many did.

Of its top-10 positions, how often did they beat the category-median stock?

Why this might matterA fund can beat its category on two positions and lose on eight; the hit rate shows the pattern the aggregate hides. The average margin then shows what the hit rate hides in turn: six winners worth a point each do not pay for four losers worth ten, and only the margin says which happened.
Why it might notSix months is short, sizing matters more than counting, and a manager who is right on the biggest position and wrong on nine small ones has done their job — the margins here are unweighted, so they answer the counting question better, not the sizing one. Overlapping disclosures judge the same position again each month it is held, so one long-held winner is counted many times. And this is a description of six months already past, not a forecast of the next six.
P6 Size against edge

₹233 Cr, 59th percentile in category; 58% of growth came from inflows

smaller than 41% of the funds in its category (160 funds) · AUM Aug 2023 → Aug 2026 · Regular plan expense ratio 0.16%

What this means. Where the fund sits by size in its category, and how much of its growth was money arriving rather than the portfolio compounding. A very large fund cannot buy what a small one can; size should buy a lower fee in return.

median holding weight, trendrisingexpense ratio, Regular / Direct0.16% / 0.00% · category median 0.16%AUM, Aug 2023 → Aug 2026₹79 Cr → ₹233 Cr (+43% a year)of that change, from flows rather than returns58% net inflows · NAV +81% over the window

Assets under management, ₹ crore, Jun 2021 – Aug 2026

100200Jun 2021Nov 2022Mar 2024Jun 2025Aug 2026Jun 2021: ₹30 CrAug 2021: ₹68 CrSep 2021: ₹104 CrOct 2021: ₹108 CrNov 2021: ₹112 CrDec 2021: ₹96 CrJan 2022: ₹113 CrFeb 2022: ₹129 CrMar 2022: ₹132 CrApr 2022: ₹113 CrJun 2022: ₹101 CrAug 2022: ₹90 CrSep 2022: ₹84 CrOct 2022: ₹87 CrNov 2022: ₹90 CrDec 2022: ₹84 CrJan 2023: ₹82 CrFeb 2023: ₹85 CrMar 2023: ₹82 Cr (amfi-aaum)Apr 2023: ₹67 CrMay 2023: ₹67 CrJun 2023: ₹72 CrAug 2023: ₹79 CrSep 2023: ₹80 CrOct 2023: ₹83 CrNov 2023: ₹85 CrDec 2023: ₹89 CrJan 2024: ₹95 CrFeb 2024: ₹103 CrMar 2024: ₹105 CrApr 2024: ₹106 CrMay 2024: ₹112 CrJun 2024: ₹121 CrAug 2024: ₹134 CrSep 2024: ₹146 CrOct 2024: ₹150 CrNov 2024: ₹106 CrDec 2024: ₹155 CrJan 2025: ₹137 CrFeb 2025: ₹127 CrMar 2025: ₹127 CrApr 2025: ₹151 CrMay 2025: ₹146 CrJun 2025: ₹145 CrAug 2025: ₹142 CrSep 2025: ₹145 CrOct 2025: ₹139 CrNov 2025: ₹136 CrDec 2025: ₹132 CrJan 2026: ₹131 CrFeb 2026: ₹145 CrMar 2026: ₹155 CrApr 2026: ₹162 CrMay 2026: ₹190 CrJun 2026: ₹212 CrJul 2026: ₹229 CrAug 2026: ₹233 Cr
100200Jun 2021Nov 2022Mar 2024Jun 2025Aug 2026Jun 2021: ₹30 CrAug 2021: ₹68 CrSep 2021: ₹104 CrOct 2021: ₹108 CrNov 2021: ₹112 CrDec 2021: ₹96 CrJan 2022: ₹113 CrFeb 2022: ₹129 CrMar 2022: ₹132 CrApr 2022: ₹113 CrJun 2022: ₹101 CrAug 2022: ₹90 CrSep 2022: ₹84 CrOct 2022: ₹87 CrNov 2022: ₹90 CrDec 2022: ₹84 CrJan 2023: ₹82 CrFeb 2023: ₹85 CrMar 2023: ₹82 Cr (amfi-aaum)Apr 2023: ₹67 CrMay 2023: ₹67 CrJun 2023: ₹72 CrAug 2023: ₹79 CrSep 2023: ₹80 CrOct 2023: ₹83 CrNov 2023: ₹85 CrDec 2023: ₹89 CrJan 2024: ₹95 CrFeb 2024: ₹103 CrMar 2024: ₹105 CrApr 2024: ₹106 CrMay 2024: ₹112 CrJun 2024: ₹121 CrAug 2024: ₹134 CrSep 2024: ₹146 CrOct 2024: ₹150 CrNov 2024: ₹106 CrDec 2024: ₹155 CrJan 2025: ₹137 CrFeb 2025: ₹127 CrMar 2025: ₹127 CrApr 2025: ₹151 CrMay 2025: ₹146 CrJun 2025: ₹145 CrAug 2025: ₹142 CrSep 2025: ₹145 CrOct 2025: ₹139 CrNov 2025: ₹136 CrDec 2025: ₹132 CrJan 2026: ₹131 CrFeb 2026: ₹145 CrMar 2026: ₹155 CrApr 2026: ₹162 CrMay 2026: ₹190 CrJun 2026: ₹212 CrJul 2026: ₹229 CrAug 2026: ₹233 Cr
100200Jun 2021Nov 2022Mar 2024Jun 2025Aug 2026Jun 2021: ₹30 CrAug 2021: ₹68 CrSep 2021: ₹104 CrOct 2021: ₹108 CrNov 2021: ₹112 CrDec 2021: ₹96 CrJan 2022: ₹113 CrFeb 2022: ₹129 CrMar 2022: ₹132 CrApr 2022: ₹113 CrJun 2022: ₹101 CrAug 2022: ₹90 CrSep 2022: ₹84 CrOct 2022: ₹87 CrNov 2022: ₹90 CrDec 2022: ₹84 CrJan 2023: ₹82 CrFeb 2023: ₹85 CrMar 2023: ₹82 Cr (amfi-aaum)Apr 2023: ₹67 CrMay 2023: ₹67 CrJun 2023: ₹72 CrAug 2023: ₹79 CrSep 2023: ₹80 CrOct 2023: ₹83 CrNov 2023: ₹85 CrDec 2023: ₹89 CrJan 2024: ₹95 CrFeb 2024: ₹103 CrMar 2024: ₹105 CrApr 2024: ₹106 CrMay 2024: ₹112 CrJun 2024: ₹121 CrAug 2024: ₹134 CrSep 2024: ₹146 CrOct 2024: ₹150 CrNov 2024: ₹106 CrDec 2024: ₹155 CrJan 2025: ₹137 CrFeb 2025: ₹127 CrMar 2025: ₹127 CrApr 2025: ₹151 CrMay 2025: ₹146 CrJun 2025: ₹145 CrAug 2025: ₹142 CrSep 2025: ₹145 CrOct 2025: ₹139 CrNov 2025: ₹136 CrDec 2025: ₹132 CrJan 2026: ₹131 CrFeb 2026: ₹145 CrMar 2026: ₹155 CrApr 2026: ₹162 CrMay 2026: ₹190 CrJun 2026: ₹212 CrJul 2026: ₹229 CrAug 2026: ₹233 Cr

57 points · months without a factsheet figure use AMFI's quarterly average · Regular-plan expense ratio 0.15% in May 2021 → 0.16% in Sep 2026

How it is measured, and the case against

Past a certain size the smaller end of a mandate becomes unreachable, and the fund starts to look like its index; what size should buy in return is a lower expense ratio.

Has the fund outgrown the universe it invests in — and did size buy a lower fee?

Why this might matterSize narrows what the manager can meaningfully hold and should lower what the investor pays. Read the AUM history beside the expense ratio: a fund that has tripled through inflows while its Regular-plan TER sits above the category median has kept the benefit of scale for the house. The flow decomposition says how much of the growth was money arriving rather than the portfolio compounding.
Why it might notScale funds research teams, and plenty of large funds have gone on compounding for decades. Inflows follow performance, so a fund growing fast is usually one that did well; the constraint is real but not automatically binding, and a TER is a ceiling the AMC can cut at any time.
P7 Whose record is this headline and record disagree

Run by Nishit Patel for 5.3 yrs

with Ashwini Bharucha, Venus Ahuja

What this means. How long the people running it now have been running it, read from the monthly factsheets. A five-year record earned under someone else is not evidence about these managers.

running it nowNishit Patel (since May 2021), Ashwini Bharucha (since Nov 2024), Venus Ahuja (since Nov 2025)share of the fund's life under the longest-serving current manager100%changes of hands in the archive8 — last Oct 2025

Who ran it, month by month · factsheets through Sep 2026

running it nowearlier
ManagerRoleFromToFund vs category, those months3-yr stretches won in tenure
Nishit Patel fund manager May 2021 now 14.9% vs 11.4% p.a. (+3.46 pp) 89% of 28
Ashwini Bharucha fund manager Nov 2024 now 9.7% vs 2.9% p.a. (+6.81 pp)
Venus Ahuja fund manager Oct 2025 now 20.3% vs 3.7% (+16.51 pp)
Kayzad Eghlim fund manager May 2021 Dec 2023 10.2% vs 16.1% p.a. (−5.95 pp)
Kewal Shah fund manager Jan 2024 May 2024 11.0% vs 5.4% (+5.61 pp)
Priya Sridhar fund manager Jan 2024 Nov 2024 33.4% vs 14.1% (+19.24 pp)
Kewal Shah fund manager Feb 2024 Nov 2024 24.2% vs 13.3% (+10.98 pp)
Aswini Shinde fund manager Oct 2024 Oct 2024 −2.2% vs −5.7% (+3.50 pp)
Ashwini Shinde fund manager Nov 2024 Aug 2025 −0.1% vs 0.5% (−0.56 pp)

* dated by first appearance in the archive we hold, not by a date the factsheet printed. Co-managed months count for every manager named; a factsheet names the manager of record, not who made each call. All managers →

The 5-year figure covers most of the fund's entire life. This scheme is about 5.4 years old and a 5-year return is being displayed for it. That is effectively a since-inception number — it measures the period the fund happened to be launched into, and separates nothing from the manager's contribution.
How it is measured, and the case against

A record earned under different people is not evidence about these ones.

Does the displayed record predate the people running it?

Why this might matterA five-year figure on a fund whose longest-serving manager joined two years ago is the house's record more than the person's. The tenure here comes from what each monthly factsheet named, so a change of hands is dated to the month it was disclosed, and the fund's return against its category can be read over exactly those months.
Why it might notEvery fund is young once, and a short record is not a bad one. This says the number cannot bear the weight usually placed on it, not that the fund is worse than a peer.

Tracking gap

the NAV the fund published, against the NAV its last disclosed portfolio would have produced at each day's prices

No signal. Replication needs a fully disclosed domestic-equity portfolio and daily prices for every line; this fund has not been replicated in this build.

Share classes

latest NAV per AMFI code

PlanOptionNAVDate
regular
ICICI Prudential Nifty Healthcare ETF
₹172.4421 Sep 2026
The Direct / Regular gap, in rupees

This fund does not have both a Direct and a Regular growth class in the data, so the gap cannot be measured.

A Regular plan buys advice. The fee is visible and the behavioural saving is not; both are shown, neither is netted off.

Compare with

same category, by size